Fra-1/AP-1 impairs inflammatory responses and chondrogenesis in fracture healing

Journal of Bone and Mineral Research

Volumn 24, Issue 12, 2009, Pages 2056-2065

  Yamaguchi, Toru ^a   Takada, Yasunari ^a   Maruyama, Kenta ^a   Shimoda, Kouji ^a   Arai, Yoshinori ^b   Nango, Nobuhito ^c   Kosaki, Naoto ^a   Takaishi, Hironari ^a   Toyama, Yoshiaki ^a   Matsuo, Koichi ^a  

^a KEIO UNIVERSITY   (Japan)

^b NIHON UNIVERSITY   (Japan)

^c Ratoc System Engineering Co Ltd   (Japan)

Author keywords

Cytokines; Gene regulation; Inflammation; Rodent

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CYCLOOXYGENASE 2; INTERLEUKIN 6; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR SOX9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CALLUS; CHONDROGENESIS; CONTROLLED STUDY; DIAPHYSIS; FEMALE; FRACTURE HEALING; HISTOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RADIODIAGNOSIS; TIBIA; TRANSGENIC MOUSE;

ANIMALS; CHONDROGENESIS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRACTURE HEALING; INFLAMMATION MEDIATORS; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-FOS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR AP-1;

EID: 73849091390     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090603     Document Type: Article

References (39)

1. Gerstenfeld LC, Einhorn TA 2006 Fracture healing: The biology of bone repair and regeneration. In: Favus MJ (ed.) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th ed. American Society for Bone and Mineral Research, Washington, DC, USA, pp. 42-48.
2. Maes C, Coenegrachts L, Stockmans I, Daci E, Luttun A, Petryk A, Gopalakrishnan R, Moermans K, Smets N, Verfaillie CM, Carmeliet P, Bouillon R, Carmeliet G 2006 Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 116:1230-1242.
3. Vortkamp A, Pathi S, Peretti GM, Caruso EM, Zaleske DJ, Tabin CJ 1998 Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair. Mech Dev 71:65-76.
4. Ferguson C, Alpern E, Miclau T, Helms JA 1999 Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:57-66.
5. Gerstenfeld LC, Cho TJ, Kon T, Aizawa T, Tsay A, Fitch J, Barnes GL, Graves DT, Einhorn TA 2003 Impaired fracture healing in the absence of TNF-α signaling: The role of TNF-α in endochondral cartilage resorption. J Bone Miner Res 18:1584-1592.
6. Wagner EF, Eferl R 2005 Fos/AP-1 proteins in bone and the immune system. Immunol Rev 208:126-140.
7. Matsuo K, Ray N 2004 Osteoclasts, mononuclear phagocytes, and c-Fos: New insight into osteoimmunology. Keio J Med 53:78-84.
8. Ray N, Kuwahara M, Takada Y, Maruyama K, Kawaguchi T, Tsubone H, Ishikawa H, Matsuo K 2006 c-Fos suppresses systemic inflammatory response to endotoxin. Int Immunol 18:671-677.
9. Maruyama K, Sano G, Ray N, Takada Y, Matsuo K 2007 c-Fos-deficient mice are susceptible to Salmonella enterica serovar Typhimurium infection. Infect Immun 75:1520-1523.
10. Jochum W, David JP, Elliott C, Wutz A, Plenk H Jr, Matsuo K, Wagner EF 2000 Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat Med 6:980-984.
11. Eferl R, Hoebertz A, Schilling AF, Rath M, Karreth F, Kenner L, Amling M, Wagner EF 2004 The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 23:2789-2799.
12. Sabatakos G, Sims NA, Chen J, Aoki K, Kelz MB, Amling M, Bouali Y, Mukhopadhyay K, Ford K, Nestler EJ, Baron R 2000 Overexpression of ΔFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat Med 6:985-990.
13. Roschger P, Matsuo K, Misof BM, Tesch W, Jochum W, Wagner EF, Fratzl P, Klaushofer K 2004 Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1. Bone 34:776-782.
14. Shimoaka T, Kamekura S, Chikuda H, Hoshi K, Chung UI, Akune T, Maruyama Z, Komori T, Matsumoto M, Ogawa W, Terauchi Y, Kadowaki T, Nakamura K, Kawaguchi H 2004 Impairment of bone healing by insulin receptor substrate-1 deficiency. J Biol Chem 279:15314-15322.
15. Nagy A, Gertsenstein M, Vintersten K, Behringer R 2003 Buffers and Solutions (Appendix 1) Manupulating the Mouse Embryo: A Laboratory Manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
16. Bonnarens F, Einhorn TA 1984 Production of a standard closed fracture in laboratory animal bone. J Orthop Res 2:97-101.
17. Sims NA, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coschigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA 2000 Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 106:1095-1103.
18. Saunders MA, Sansores-Garcia L, Gilroy DW, Wu KK 2001 Selective suppression of CCAAT/enhancer-binding protein β binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblasts. J Biol Chem 276:18897-18904.
19. Zhao C, Irie N, Takada Y, Shimoda K, Miyamoto T, Nishiwaki T, Suda T, Matsuo K 2006 Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4:111-121.
20. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
21. Simon AM, Manigrasso MB, O'Connor JP 2002 Cyclooxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 17:963-976.
22. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ 2002 Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 109:1405-1415.
23. Uusitalo H, Hiltunen A, Ahonen M, Gao TJ, Lefebvre V, Harley V, Kahari VM, Vuorio E 2001 Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing. J Bone Miner Res 16:1837-1845.
24. Kugimiya F, Kawaguchi H, Kamekura S, Chikuda H, Ohba S, Yano F, Ogata N, Katagiri T, Harada Y, Azuma Y, Nakamura K, Chung UI 2005 Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation. J Biol Chem 280:35704-35712.
25. Tsuji K, Bandyopadhyay A, Harfe BD, Cox K, Kakar S, Gerstenfeld L, Einhorn T, Tabin CJ, Rosen V 2006 BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38:1424-1429.
26. Morishita H, Saito F, Kayama H, Atarashi K, Kuwata H, Yamamoto M, Takeda K 2009 Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses. Int Immunol 21:457-465.
27. Lehmann W, Edgar CM, Wang K, Cho TJ, Barnes GL, Kakar S, Graves DT, Rueger JM, Gerstenfeld LC, Einhorn TA 2005 Tumor necrosis factor alpha (TNF-α) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 36:300-310.
28. Murakami S, Lefebvre V, de Crombrugghe B 2000 Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor-α. J Biol Chem 275:3687-3692.
29. Feng JQ, Xing L, Zhang JH, Zhao M, Horn D, Chan J, Boyce BF, Harris SE, Mundy GR, Chen D 2003 NF-κB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 278:29130-29135.
30. Csiszar A, Smith KE, Koller A, Kaley G, Edwards JG, Ungvari Z 2005 Regulation of bone morphogenetic protein-2 expression in endothelial cells: Role of nuclear factor-κB activation by tumor necrosis factor-α, H2O2, and high intravascular pressure. Circulation 111:2364-2372.
31. Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, Yamane S, Suzuki R, Sandell LJ, Ochi T 2006 Pro-inflammatory cytokine tumor necrosis factor-α induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem 281:27229-27241.
32. Li M, Healy DR, Li Y, Simmons HA, Crawford DT, Ke HZ, Pan LC, Brown TA, Thompson DD 2005 Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice. Bone 37:46-54.
33. Li M, Ke HZ, Qi H, Healy DR, Li Y, Crawford DT, Paralkar VM, Owen TA, Cameron KO, Lefker BA, Brown TA, Thompson DD 2003 A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 18:2033-2042.
34. Naik AA, Xie C, Zuscik MJ, Kingsley P, Schwarz EM, Awad H, Guldberg R, Drissi H, Puzas JE, Boyce B, Zhang X, O'Keefe RJ 2009 Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J Bone Miner Res 24:251-264.
35. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL 2007 The hypoxia-inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117:1616-1626.
36. Robins JC, Akeno N, Mukherjee A, Dalal RR, Aronow BJ, Koopman P, Clemens TL 2005 Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 37:313-322.
37. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH 2002 Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661.
38. Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, Jacobsen KA, Alaql ZS, Eberhardt AW, Gerstenfeld LC, Einhorn TA, Deng L, Clemens TL 2008 Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration. Proc Natl Acad Sci USA 105:686-691.
39. Khosla S, Westendorf JJ, Oursler MJ 2008 Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118: 421-428.